1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. Global Cancer Biomarkers Market by type
5.1. Introduction
5.2. Protein Biomarkers
5.3. Genetic Biomarkers
5.4. Others
6. Global Cancer Biomarkers Market by cancer type
6.1. Introduction
6.2. Melanoma
6.3. Lung cancer
6.4. Thyroid cancer
6.5. Kidney cancer
6.6. Breast Cancer
6.7. Others
7. Global Cancer Biomarkers Market by Application
7.1. Introduction
7.2. Diagnosis
7.3. Drug Discovery and Development
7.4. Prognosis
7.5. Risk Assessment
8. Global Cancer Biomarkers Market by end-user
8.1. Introduction
8.2. Hospitals and Clinics
8.3. Diagnostic Centers
9. Global Cancer Biomarkers Market by geography
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. United Kingdom
9.4.2. Germany
9.4.3. France
9.4.4. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. Japan
9.6.3. India
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Oxford Cancer Biomarkers Ltd
11.2. Janssen Global Services, LLC
11.3. Cynvenio Biosystems, Inc
11.4. Human Longevity Inc
11.5. Abcodia Ltd
11.6. Indivumed GmbH
11.7. Caris Life Sciences
11.8. BCAL Diagnostics
11.9. Cellanyx, LLC
11.10. Cancer Genetics Inc.
11.11. F. Hoffmann-La Roche Ltd
11.12. Illumina, Inc.
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES